Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Elsevier Business Intelligence

17:46 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "Elsevier Business Intelligence" found in our extensive news archives from over 250 global news sources.

More Information about Elsevier Business Intelligence on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Elsevier Business Intelligence for you to read. Along with our medical data and news we also list Elsevier Business Intelligence Clinical Trials, which are updated daily. BioPortfolio also has a large database of Elsevier Business Intelligence Companies for you to search.

Showing News Articles 1–25 of 1,700+ from Elsevier Business Intelligence

Tuesday 14th August 2018

Stand-Off: Vertex Refuses NICE Data on CF Drug Symkevi, HTA Body Awaits Next Move

Vertex says it will not file data on its cystic fibrosis drug Symkevi (tezacaftor/ivacaftor) until the UK's NICE changes ...

UK MHRA Spells Out Do's And Don'ts Of Real-World Evidence For Showing Efficacy

A senior UK regulator explains why the MHRA agreed to a complex real-world evidence study instead of an RCT to...  ...

Monday 13th August 2018

Ambys Medicines launches with $60mm Series A round

Recently formed regenerative therapies firm Ambys Medicines launched with a $60mm Series A round provided by Third Rock Ventu...

BioCryst nets $54mm via FOPO

BioCryst Pharmaceuticals Inc. netted $54mm through the follow-on public offering of 10.45mm common shares (including full exe...

Glaukos, D. Western Therapeutics ally in glaucoma

Glaukos Corp. and Japanese biotech D. Western Therapeutics Institute Inc. (DWTI) are teaming up to create new glaucoma therap...

Boston Scientific to acquire the rest of Veniti for $108mm plus earn-outs

Boston Scientific Corp. agreed to paid $108mm in cash up front to acquire the remaining 75% of cardiovascular stent developer...

Public offering nets $35mm for Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals Inc. (drug development using its small molecule nucleic acid hybrid (SMNH) chemistry platform) ne...

Vaccinex nets $37.2mm through IPO

Vaccinex Inc. (biotherapeutic mAbs for cancer, neurodegenerative diseases, and autoimmune disorders) netted $37.2mm in an ini...

REGENXBIO nets $165mm through latest follow-on offering

REGENXBIO Inc. (gene therapies for retinal, metabolic, and neurodegenerative diseases) netted $165mm through the public sale ...

Probable Carcinogen Found Haunting More Firms’ Valsartan API

As Zhejiang Huahai works to rid its valsartan API manufacturing process of NDMA impurity, two competitors also have launched ...

Alexion’s Soliris Successor Among New Drugs Under EMA Review

Alexion Pharmaceuticals’ successor to its blockbuster Soliris is among the new investigational drugs being reviewed for EU ...

ICH Evaluates Guideline Uptake By New And Old Members

The study will be undertaken by an independent third party and its results will help facilitate a transparent dialogue on...&...

Spain Investigates Metamizole Risks In Expat Britons

Metamizole is in the safety spotlight again after the Spanish regulator said it was investigating reports of deaths and serio...

Saturday 11th August 2018

Karolinska University Hospital And GE Healthcare Collaborate To Advance Technologies For Cell Therapy

Karolinska University Hospital Sweden and GE Healthcare Life Sciences recently announced a joint research collaboration to dr...

GE Healthcare Life Sciences Launches Capto™ L Chromatography Medium For Capture Of Antibodies And Antibody Fragments

GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. ...

GE Healthcare And BAC Collaborate To Launch New Bioprocess Affinity Resin

GE Healthcare, the healthcare business of GE and BAC BV, the leading provider of antibody-based affinity purification technol...

Friday 10th August 2018

Ampio Pharmaceuticals nets $7.4mm in follow-on

Ampio Pharmaceuticals Inc. (inflammatory-focused therapeutics) netted $7.4mm in a follow-on public offering of 20mm common sh...

Regeneron and bluebird bio enter cell therapy pact

Regeneron Pharmaceuticals Inc. and bluebird bio Inc. will lean on each other’s platform discoveries to together discover an...

Sarepta licenses Pompe program from Lacerta, options two CNS candidates

Sarepta Therapeutics Inc. licensed exclusive worldwide rights to Lacerta Therapeutics Inc.'s gene therapy candidate for Pompe...

Zogenix FOPO brings in $293mm

CNS-focused orphan drug developer Zogenix Inc. netted $293.3mm in a public offering of 6mm shares at $52. The company will us...

RedHill Biopharma nets $23.7mm through FOPO

RedHill Biopharma Ltd. netted $23.7mm in a public offering of 4.2mm American Depositary Shares (ADSs) at $6 per ADS. (Each AD...

Ampio Pharmaceuticals grosses $8mm in follow-on

Ampio Pharmaceuticals Inc. (inflammatory-focused therapeutics) grossed $8mm in a follow-on public offering of 20mm common sha...

Evidation completes $30mm Series C round

Evidation Health Inc. (tracking, analysis, and processing of large-scale sensor and behavior data using mobile apps and weara...

Public offering nets $117.5mm for NeoGenomics

NeoGenomics Inc. netted $117.5mm through a public offering of 9.8mm common shares at $12.75. The company offers genetic testi...

Bausch Health Boosts Ad Spending For Expanding OTC Eye Care Lineup

"We're investing more to drive growth as we allocate capital to support the launches of new products in the segment....


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks